English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily Report | Aug 8, 2023

Fiagon North America VP lauds 'encouraging and successful' American Rhinologic Society sinus symposium

Patient Daily Report | Jul 28, 2023

National Breathe Free CEO: 'What made this year's convention truly exceptional was the celebration of individual contributions and the cumulative achievements of our incredible team members.'

Patient Daily Report | Jul 18, 2023

Dr. Pollet: 'This first procedure is a huge milestone in our journey to help patients find relief'

Patient Daily Report | Jul 18, 2023

Joe Landolina: "The FDA clearance sets the predicate for our advanced technology and marks Cresilon's first step towards actualizing our long-term goal of expanding our technology within the broader human health market."

Patient Daily Report | Jul 18, 2023

Kidneys for Communities: 'The Kidneys for First Responders initiative connects those who want to support firefighters, EMTs and police officers by facilitating the living kidney donation'

Patient Daily Report | Jul 18, 2023

BioArctic CEO: FDA approval of Leqembi 'is a paradigm-shifting step in the fight against Alzheimer's disease'

Patient Daily Report | Jul 18, 2023

USGS' Smalling: 'The study estimates that at least one type of PFAS ... could be present in nearly half of the tap water in the U.S.'

Patient Daily Report | Jul 18, 2023

Woodgrift: 'Leadless pacemakers have been limited to a single chamber device,' until approval of Abbot's new AVEIR DR system

Trending

Patient Daily | Jul 15, 2025

Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating

Patient Daily | Jul 11, 2025

Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’

Patient Daily | Jul 15, 2025

Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating

+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'

  • « First
  • «
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily